Puretech Health Plc Stock Price To Earnings To Growth
| PTCHFDelisted Stock | USD 3.13 0.00 0.00% |
PureTech Health plc fundamentals help investors to digest information that contributes to PureTech Health's financial success or failures. It also enables traders to predict the movement of PureTech Pink Sheet. The fundamental analysis module provides a way to measure PureTech Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PureTech Health pink sheet.
PureTech |
PureTech Health plc Company Price To Earnings To Growth Analysis
PureTech Health's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, PureTech Health plc has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
PureTech Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PureTech Health's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PureTech Health could also be used in its relative valuation, which is a method of valuing PureTech Health by comparing valuation metrics of similar companies.PureTech Health is currently under evaluation in price to earnings to growth category among its peers.
PureTech Fundamentals
| Return On Equity | -0.0152 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.73) % | ||||
| Operating Margin | (9.87) % | ||||
| Current Valuation | 654.5 M | ||||
| Shares Outstanding | 278.81 M | ||||
| Shares Owned By Insiders | 15.48 % | ||||
| Shares Owned By Institutions | 72.20 % | ||||
| Price To Earning | 158.00 X | ||||
| Price To Book | 1.61 X | ||||
| Price To Sales | 51.23 X | ||||
| Revenue | 9.98 M | ||||
| Gross Profit | 17.39 M | ||||
| EBITDA | (46.95 M) | ||||
| Net Income | (60.56 M) | ||||
| Cash And Equivalents | 368.03 M | ||||
| Cash Per Share | 1.28 X | ||||
| Total Debt | 14.26 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 2.54 X | ||||
| Book Value Per Share | 2.03 X | ||||
| Cash Flow From Operations | (158.27 M) | ||||
| Earnings Per Share | (0.21) X | ||||
| Target Price | 3.5 | ||||
| Number Of Employees | 95 | ||||
| Beta | 0.83 | ||||
| Market Capitalization | 901.7 M | ||||
| Total Asset | 946.01 M | ||||
| Z Score | 37.8 | ||||
| Net Asset | 946.01 M |
About PureTech Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PureTech Health plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PureTech Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PureTech Health plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in PureTech Pink Sheet
If you are still planning to invest in PureTech Health plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PureTech Health's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |